Ledger.Open graph →
SEC Form D · filed June 12, 2017

Swift Biosciences, Inc

Offering
$12.2M
Sold
$12.2M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Peter Kleinhenz · Ann Arbor, MIDirectorWalter Young · Ann Arbor, MIDirectorEric Halverson · Ann Arbor, MIExecTimothy Harkins, Phd · Ann Arbor, MIExec · DirectorJack Ball, Jr · Ann Arbor, MIDirectorDan Watkins · Ann Arbor, MIDirectorAlan W. Djanogly · London, United KingdomDirectorNezu Asia Capital Management Limited · Hong Kong, Hong KongExecJustin W. Slatky · New York, NYDirectorWilliam D. Cohen · Armonk, NYDirectorNicholas Longcroft · Central Hong Kong, Hong KongExec · DirectorDan Kidle · Ann Arbor, MIDirectorMark Lewis · South Norwalk, CTDirectorRobert D. Simmons · Armonk, NYDirectorGeorge Evans · Whitehouse Station, NJDirectorJohn Phinney · Wilton, CTDirectorBobby Reddy · Champaign, ILDirectorBruce V. Michelson · St. Louis, MOExecJack L. Porter · St. Louis, MOExec · DirectorDan Kidle · Ann Arbor, MIDirectorMark Lewis · ST. LOUIS, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗